Controversy: Adjunctive ablation lesions are needed beyond pulmonary vein isolation in treating persistent atrial fibrillation: Pro and Contra

Catheter ablation for persistent atrial fibrillation remains less effective than for paroxysmal atrial fibrillation, despite pulmonary vein isolation (PVI) forming the foundation of both procedures. Ablating beyond the pulmonary veins, including treatment of non-pulmonary vein triggers, posterior wall isolation, linear lesions, vein of Marshall ethanol infusion, isolation of the superior vena cava, coronary sinus or left atrial appendage, and modification of regions identified by fibrosis or low voltage has grown interest. Although observational and mechanistic studies have often been encouraging, randomized trials of empirical adjunctive ablation have produced inconsistent or neutral results. Pulsed field ablation has renewed the debate by facilitating rapid ablation of extra-pulmonary vein tissue. The PIFPAF-PFA trial did not demonstrate a significant reduction in its primary endpoint of atrial tachyarrhythmia recurrence lasting at least 30 seconds with adjunctive posterior wall isolation. However, separation of the recurrence curves and exploratory signals for reduced arrhythmia burden and fewer prolonged episodes raise questions about lesion strategy and the clinical relevance of conventional recurrence definitions. These findings do not establish routine posterior wall isolation, but they illustrate why a neutral binary endpoint may not fully characterize treatment effects on recurrent AF. The controversy now extends beyond whether additional ablation is beneficial to which mechanisms should be targeted, which patients should receive adjunctive lesions, how energy source affects lesion durability and safety, and whether success should be defined by any brief recurrence or by clinically meaningful arrhythmia burden. This article examines the evidence supporting and opposing ablation beyond PVI in persistent AF.

Authors

Institutions

Publication Details

Journal
EP Europace
Published
2026-11-18
DOI
https://doi.org/10.1093/europace/euag325
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Controversy: Adjunctive ablation lesions are needed beyond pulmonary vein isolation in treating persistent atrial fibrillation: Pro and Contra

Sanghamitra Mohanty, Luigi Di Biase, Sohaib A. Virk, Fengwei Zou et al.
1 links
EP Europace
Atrial Fibrillation Management and Outcomes
article

Controversy: Adjunctive ablation lesions are needed beyond pulmonary vein isolation in treating persistent atrial fibrillation: Pro and Contra

Sanghamitra Mohanty, Luigi Di Biase, Sohaib A. Virk, Fengwei Zou, Jonathan M. Kalman, Andrea Natale, Vincenzo Mirco La Fazia
article en

Abstract

Catheter ablation for persistent atrial fibrillation remains less effective than for paroxysmal atrial fibrillation, despite pulmonary vein isolation (PVI) forming the foundation of both procedures. Ablating beyond the pulmonary veins, including treatment of non-pulmonary vein triggers, posterior wall isolation, linear lesions, vein of Marshall ethanol infusion, isolation of the superior vena cava, coronary sinus or left atrial appendage, and modification of regions identified by fibrosis or low voltage has grown interest. Although observational and mechanistic studies have often been encouraging, randomized trials of empirical adjunctive ablation have produced inconsistent or neutral results. Pulsed field ablation has renewed the debate by facilitating rapid ablation of extra-pulmonary vein tissue. The PIFPAF-PFA trial did not demonstrate a significant reduction in its primary endpoint of atrial tachyarrhythmia recurrence lasting at least 30 seconds with adjunctive posterior wall isolation. However, separation of the recurrence curves and exploratory signals for reduced arrhythmia burden and fewer prolonged episodes raise questions about lesion strategy and the clinical relevance of conventional recurrence definitions. These findings do not establish routine posterior wall isolation, but they illustrate why a neutral binary endpoint may not fully characterize treatment effects on recurrent AF. The controversy now extends beyond whether additional ablation is beneficial to which mechanisms should be targeted, which patients should receive adjunctive lesions, how energy source affects lesion durability and safety, and whether success should be defined by any brief recurrence or by clinically meaningful arrhythmia burden. This article examines the evidence supporting and opposing ablation beyond PVI in persistent AF.

EP Europace
University of Rome Tor Vergata (IT), The Royal Melbourne Hospital (AU), Montefiore Medical Center (US), The University of Melbourne (AU), St David's Medical Center (US), Texas Cardiac Arrhythmia (US)
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon